Novo Nordisk A/S
NVO
$44.96
$0.571.28%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 7.46B | 4.19B | 3.13B | 4.03B | 4.10B |
| Total Depreciation and Amortization | 539.42M | 480.85M | 507.06M | 638.57M | 530.25M |
| Total Amortization of Deferred Charges | -- | 49.57M | -- | -- | -- |
| Total Other Non-Cash Items | 805.36M | -6.71B | 4.36B | 810.61M | 1.04B |
| Change in Net Operating Assets | -5.10B | 3.17B | -776.96M | 723.30M | -2.17B |
| Cash from Operations | 3.70B | 1.19B | 7.22B | 6.20B | 3.49B |
| Capital Expenditure | -1.74B | -2.87B | -2.13B | -2.23B | -1.89B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 156.49M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -61.57M | -3.96B | -281.49M | 62.82M | 1.05B |
| Cash from Investing | -1.80B | -6.67B | -2.42B | -2.17B | -843.41M |
| Total Debt Issued | 15.98B | 30.62B | 713.00M | 45.24B | 27.36B |
| Total Debt Repaid | -1.23B | -1.15B | -1.15B | -64.86B | -12.03B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -2.40B | 0.00 | 0.00 | 0.00 | -1.39B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.42B | 0.00 | -2.61B | -- | -4.98B |
| Other Financing Activities | 5.53B | -- | -- | -26.78B | 25.95B |
| Cash from Financing | -2.68B | 4.59B | -2.68B | -7.03B | 651.42M |
| Foreign Exchange rate Adjustments | -42.38M | 16.52M | 9.87M | -123.21M | -12.13M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -819.49M | -875.96M | 2.14B | -3.12B | 3.28B |